The problem of immune thrombocytopenia refractory to both eltrombopag and romiplostim

Hanny Al-Samkari1, Alexandra Schifferli2, Tomas J Gonzalez-Lopez3

  • 1Division of Hematology Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.

PubMed